MM13056 - New JZ Claims Modifier for Certain Medicare Part B Drugs
This new Article comprises Subregulatory Guidance for reporting requirements for new JZ modifier that will start on July 1, 2023. MLN Matters (MM) Articles are based on information contained within Change Requests (CRs). In this case, this article is based on content within CR13056 that is posted on the CMS website at https://www.cms.gov/files/document/r12067cp.pdf.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: June 02, 2023
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.